We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Screening Strategies in Drug Discovery – News and Features

A female researcher seen from the side looks across at a tablet surrounded by data symbols.
Industry Insight

Harnessing AI and Automation for the Future of Drug Discovery

In this interview, Tola Olorunnisola, senior vice president and general manager at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing the drug development process.
3D protein molecules showing the molecular backbone
Article

An Introduction to Protein Purification: Methods, Technologies and Applications

The ability to obtain pure proteins is essential for developing drugs, creating vaccines and understanding biological processes. In this article, we discuss what a typical protein purification protocol involves and the various techniques used.
Various cell types inside SemaCyte wells.
Industry Insight

Semarion Wins SLAS Europe Ignite Award 2024

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.
A gloved hand placing a vial inside an LC-MS instrument.
Article

Mass Spectrometry Imaging in Pharmaceutical Development

In this article, we explore how mass spectrometry imaging technology is evolving into a high-resolution spatial biology toolset to transform drug discovery and development.
A glowing gold trophy.
Industry Insight

SLAS Europe 2024 New Product Award Winners

Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.
Drugs of different colors, shapes and sizes in half-filled blister packs.
News

Blood Clot-Targeting Drug Candidates Developed Through Computer-Aided Design

A team of researchers has created a new series of drug candidates against a hard-to-target receptor involved in the formation of blood clots.
Therapeutic drugs next to a stethoscope and target with a dart in the bullseye.
Industry Insight

Expanding the Druggable Space With Degradation-Based Therapies

We spoke with Dr. Christian Dillon to learn more about degradation-based therapies, the challenges associated with their discovery and how innovative solutions are helping to realize the potential of this promising class of therapeutics.
A strand of RNA.
News

Tiny RNA Targets May Provide New Treatment Options for Chronic Inflammation

UC Santa Cruz researchers have discovered a peptide in human RNA that regulates inflammation and may provide a new path for treating diseases such as arthritis and lupus.
Cancer cells.
News

First-of-its-Kind Cancer Drug Shows Anti-Tumor Activity in Animal Models

Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers have developed a first-of-its-kind drug that inhibits YB-1, effectively silencing those orders.
Gloved hand holding a 96 well plate in front of a screen displaying qPCR amplification curves.
Article

qPCR vs dPCR: Choosing the Right PCR Technology To Suit Your Experimental Needs

How can you identify which technique is best suited to your research requirements? In this article, we explore the advantages of qPCR and dPCR, considering specific applications and deliverable metrics to help you choose the right technology to suit your experimental needs.
Advertisement